Tenascin-C may be a predictor of acute pulmonary thromboembolism

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 6, 2011, Pages 487-493

  Celik, Ahmet ^a   Kocyigit, Ismail ^b   Calapkorur, Bekir ^b   Korkmaz, Hasan ^a   Doganay, Emine ^b   Elcik, Deniz ^b   Ozdogru, Ibrahim ^b  

^a Elazig Education and Research Hospital ^*  (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Acute pulmonary thromboembolism; NT pro BNP; Tenascin C

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; D DIMER; TENASCIN; TROPONIN I;

ACUTE PULMONARY THROMBOEMBOLISM; ADULT; ARTERY DIAMETER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART RIGHT VENTRICLE FUNCTION; HEART SIZE; HUMAN; HYPERTENSION; LUNG EMBOLISM; PREDICTIVE VALUE; PULMONARY ARTERY; SMOKING; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; PULMONARY EMBOLISM; TENASCIN; TROPONIN I; VENTRICULAR FUNCTION, RIGHT;

EID: 79959817629     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.7070     Document Type: Article

References (36)

1. Ray P, Maziere F, Medimagh S, Lefort Y, Arthaud M, Duguet A, Teixeira A, Riou B: Evaluation of B-type natriuretic peptide to predict complicated pulmonary embolism in patients aged 65 years and older: brief report. Am J Emerg Med 2006; 24: 603-607
2. Pieralli F, Olivotto I, Vanni S, Conti A, Camaiti A, Targioni G, Grifoni S, Berni G: Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 2006; 97: 1386-1390
3. Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C, Konstantinides S: N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112: 1573-1579
4. Kostrubiec M, Pruszczyk P, Bochowicz A, Pacho R, Szulc M, Kaczynska A, Styczynski G, Kuch-Wocial A, Abramczyk P, Bartoszewicz Z, Berent H, Kuczynska K: Biomarkerbased risk assessment model in acute pulmonary embolism. Eur Heart J 2005; 26: 2166-2172
5. Krüger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, Janssens U: Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004; 147: 60-65
6. Pruszczyk P, Kostrubiec M, Bochowicz A, Styczynski G, Szulc M, Kurzyna M, Fijalkowska A, Kuch-Wocial A, Chlewicka I, Torbicki A: N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003; 22: 649-653
7. Hedin U, Holm J, Hansson GK: Induction of tenascin in rat arterial injury: Relationship to altered smooth muscle cell phenotype. Am J Pathol 1991; 139: 649-656
8. LaFleur DW, Chiang J, Fagin JA, Schwartz SM, Shah PK, Wallner K, Forrester JS, Sharifi BG: Aortic smooth muscle cells interact with tenascin-C through its fibrinogenlike domain. J Biol Chem 1997; 272: 32798-32803
9. Maseruka H, Ridgway A, Tullo A, Bonshek R: Developmental changes in patterns of expression of tenascin-C variants in the human cornea. Invest Ophthalmol Vis Sci 2000; 41: 4101-4107
10. Cowan KN, Jones PL, Rabinovitch M: Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 1999; 84: 1223-1233
11. Wallner K, Li C, Shah PK, Fishbein MC, Forrester JS, Kaul S, Sharifi BG: Tenascin- C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation 1999; 99: 1284-1289
12. Satta J, Soini Y, Pollanen R, Paakko P, Juvonen T: Tenascin expression is associated with a chronic inflammatory process in abdominal aortic aneurysms. J Vasc Surg 1997; 26: 670-675
13. Imanaka-Yoshida K, Hiroe M, Nishikawa T, Ishiyama S, Shimojo T, Ohta Y, Sakakura T, Yoshida T: Tenascin- C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest 2001; 81: 1015-1024
14. Willems IE, Arends JW, Daemen MJ: Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 1996; 179: 321-325
15. Jahkola T, Toivonen T, Nordling S, von Smitten K, Virtanen I: Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer 1998; 34: 1687-1692
16. Jahkola T, Toivonen T, Virtanen I, von Smitten K, Nordling S, von Boguslawski K, Haglund C, Nevanlinna H, Blomqvist C: Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 1998; 78: 1507-1513
17. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y: Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal cancer. Cancer 2001; 92: 1419-1426
18. Salmenkivi K, Haglund C, Arola J, Heikkilä P: Increased expression of tenascin in pheochromocytomas correlates with malignancy. Am J Surg Pathol 2001; 25: 1419-1423
19. Jones PL, Cowan KN, Rabinovitch M: Tenascin- C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 1997; 150: 1349-1360
20. Jones PL, Rabinovitch M: Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res 1996; 79: 1131-1142
21. Cowan KN, Jones PL, Rabinovitch M: Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 2000; 105: 21-34
22. Cowan KN, Jones PL, Rabinovitch M: Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 1999; 84: 1223-1233
23. Jeffery TK, Wanstall JC: Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001; 92: 1-20
24. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M: Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000; 6: 698-702
25. Kircher BJ, Himelman RB, Schiller NB: Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66: 493-496
26. Grau E, Tenías JM, Soto MJ, Gutierrez MR, Lecumberri R, Pérez JL, Tiberio G; RIETE Investigators: D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry. Crit Care Made 2007; 35; 1937-1941
27. Mehta NJ, Jani K, Khan IA: Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am Heart J 2003; 145: 821-825
28. Gallotta G, Palmieri V, Piedimonte V, Rendina D, De Bonis S, Russo V, Celentano A, Di Minno MN, Postiglione A, Di Minno G: Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with sub-massive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information. Int J Cardiol 2008; 124: 351-357
29. Patanè S, Marte F, La Rosa FC, Di Bella G, La Rocca R, Villari SA: Abnormal troponin I levels in acute pulmonary embolism without abnormal concentrations of D-dimer at admission. Int J Cardiol 2010; 138: 104-105.
30. Amorim S, Dias P, Rodrigues RA: Troponin I as a marker of right ventricular dysfunction and severity of pulmonary embolism. Rev Port Cardiol 2006; 25: 181-186
31. Imanaka-Yoshida K, Hiroe M, Yasutomi Y, Toyozaki T, Tsuchiya T, Noda N, Maki T, Nishikawa T, Sakakura T, Yoshida T: Tenascin- C is a useful marker for disease activity in myocarditis. J Pathol 2002; 197: 388-394
32. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukho-va GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999; 99: 3063-3070
33. Sato A, Aonuma K, Imanaka-Yoshida K, Yoshida T, Isobe M, Kawase D, Kinoshita N, Yazaki Y, Hiroe M: Serum tenascin- C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol 2006; 47: 2319-2325
34. Schumann C, Lepper PM, Frank H: Circulating biomarkers of tissue remodelling in pulmonary hypertension. Biomarkers 2010; Jun 9
35. Chin KM, Rubin LJ: Pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51: 1527-1538
36. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T: Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 2005; 167: 71-80